Literature DB >> 10449428

Stemming bone loss by suppressing apoptosis.

J M Hock1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10449428      PMCID： PMC408531          DOI： 10.1172/JCI7991

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  34 in total

Review 1.  Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence.

Authors:  F Cosman; R Lindsay
Journal:  Calcif Tissue Int       Date:  1998-06       Impact factor: 4.333

2.  Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone.

Authors:  T Onishi; K Hruska
Journal:  Endocrinology       Date:  1997-05       Impact factor: 4.736

3.  Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.

Authors:  T Hirano; D B Burr; C H Turner; M Sato; R L Cain; J M Hock
Journal:  J Bone Miner Res       Date:  1999-04       Impact factor: 6.741

4.  Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin.

Authors:  L R Chaudhary; L V Avioli
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

5.  Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro.

Authors:  J E Onyia; B Miller; J Hulman; J Liang; R Galvin; C Frolik; S Chandrasekhar; A K Harvey; J Bidwell; J Herring; J M Hock
Journal:  Bone       Date:  1997-02       Impact factor: 4.398

6.  Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice.

Authors:  W Zhao; M H Byrne; B F Boyce; S M Krane
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

7.  Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone.

Authors:  P McClelland; J E Onyia; R R Miles; Y Tu; J Liang; A K Harvey; S Chandrasekhar; J M Hock; J P Bidwell
Journal:  J Cell Biochem       Date:  1998-09-01       Impact factor: 4.429

8.  Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat.

Authors:  P H Watson; L J Fraher; M Kisiel; D DeSousa; G Hendy; A B Hodsman
Journal:  Bone       Date:  1999-02       Impact factor: 4.398

9.  Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

Authors:  N E Lane; S Sanchez; G W Modin; H K Genant; E Pierini; C D Arnaud
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

10.  Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.

Authors:  R T Turner; G L Evans; J M Cavolina; B Halloran; E Morey-Holton
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736
View more
  4 in total

Review 1.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  PTH and PTHrP effects on the skeleton.

Authors:  A C Karaplis; D Goltzman
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 3.  Anabolic agents and bone quality.

Authors:  Tarek Sibai; Elise F Morgan; Thomas A Einhorn
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

4.  Vascular endothelial growth factor regulates osteoblast survival - evidence for an autocrine feedback mechanism.

Authors:  John Street; Brian Lenehan
Journal:  J Orthop Surg Res       Date:  2009-06-16       Impact factor: 2.359
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.